Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Donepezil may help lessen confusion and fatigue and improve mood and quality of
life in patients who have undergone radiation therapy for brain tumors. It is not yet known
whether donepezil is more effective than a placebo in lessening side effects of radiation
therapy in patients with brain tumors.
PURPOSE: This randomized phase III trial is studying donepezil to see how well it works in
lessening side effects of radiation therapy compared with a placebo in patients who have
undergone radiation therapy for brain tumors.
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest University Wake Forest University Health Sciences